Subcutaneous versus intravenous nivolumab for renal cell carcinoma von Albiges, L., Bourlon, M.T., Chacón, M., Cutuli, H.J., Chuken, Y.A.L., Żurawski, B., Mota, J.M., Magri, I., Burotto, M., Luz, M., de Menezes, J., Ruiz, E.P.Y., Fu, S., Richardet, M., Valderrama, B.P., Maruzzo, M., Bracarda, S., Breckenridge, M., Vezina, H.E., Rathod, D., Yu, Z., Zhao, Y., Dixon, M., Perumal, D., George, S.

Volltext

More on sunitinib 2 weeks on/1 week off schedule: the Rainbow analysis von Basso, U., Maruzzo, M.

Volltext

Neutrophil-to-lymphocyte ratio and lactate dehydrogenase as biomarkers for urothelial cancer treated with immunotherapy von Banna, G. L., Di Quattro, R., Malatino, L., Fornarini, G., Addeo, A., Maruzzo, M., Urzia, V., Rundo, F., Lipari, H., De Giorgi, U., Basso, U.

Volltext

Immune-inflammatory biomarkers as prognostic factors for immunotherapy in pretreated advanced urinary tract cancer patients: an analysis of the Italian SAUL cohort von Fornarini, G., Rebuzzi, S.E., Banna, G.L., Calabrò, F., Scandurra, G., De Giorgi, U., Masini, C., Baldessari, C., Naglieri, E., Caserta, C., Manacorda, S., Maruzzo, M., Milella, M., Buttigliero, C., Tambaro, R., Ermacora, P., Morelli, F., Nolè, F., Astolfi, C., Sternberg, C.N.

Volltext

Patient Reported Outcomes, Paternity, Relationship, and Fertility in Testicular Cancer Survivors: Results from a Prospective Observational Single Institution Trial von Bimbatti, Davide, Lai, Eleonora, Pierantoni, Francesco, Maruzzo, Marco, Msaki, Aichi, De Toni, Chiara, Dionese, Michele, Feltrin, Alessandra, Basso, Umberto, Zagonel, Vittorina

Volltext

Safety and activity of sunitinib in elderly patients (≥70 years) with metastatic renal cell carcinoma: a multicenter study von Brunello, A., Basso, U., Sacco, C., Sava, T., De Vivo, R., Camerini, A., Barile, C., Roma, A., Maruzzo, M., Falci, C., Zagonel, V.

Volltext

Validation of the Meet-URO score in patients with metastatic renal cell carcinoma receiving first-line nivolumab and ipilimumab in the Italian Expanded Access Program von Rebuzzi, S.E., Signori, A., Buti, S., Banna, G.L., Murianni, V., Damassi, A., Maruzzo, M., Giannarelli, D., Tortora, G., Galli, L., Rizzo, M., De Giorgi, U., Antonuzzo, L., Bracarda, S., Cartenì, G., Atzori, F., Tamberi, S., Procopio, G., Fratino, L., Lo Re, G., Santoni, M., Baldessari, C., Astone, A., Calabrò, F., Brunelli, M., Porta, C., Rescigno, P., Basso, U., Fornarini, G.

Volltext

Isolated Limb Perfusion for the Management Limb Threatening Soft Tissue Sarcomas: The Role of Histological Type on Clinical Outcomes von Rastrelli, Marco, M.D, Mocellin, Simone, M.D, Stramare, Roberto, M.D, Brunello, Antonella, M.D, Maruzzo, Marco, M.D, Basso, Umberto, M.D, Scarzello, Giovanni, M.D, Buzzaccarini, Maria Samaritana, M.D, Pilati, Pierluigi, M.D, Saadeh, Luca Maria, M.D, Del Fiore, Santo Paolo, D.M, Tosi, Annalisa, M.D, Montesco, Cristina, M.D, Campana, Luca Giovanni, M.D, Tropea, Saveria, M.D, Rossi, Carlo Riccardo, M.D

Volltext

Extra-nodal extension of sentinel lymph node metastasis is a marker of poor prognosis in breast cancer patients: A systematic review and an exploratory meta-analysis von Nottegar, A, Veronese, N, Senthil, M, Roumen, R.M, Stubbs, B, Choi, A.H, Verheuvel, N.C, Solmi, M, Pea, A, Capelli, P, Fassan, M, Sergi, G, Manzato, E, Maruzzo, M, Bagante, F, Koç, M, Eryilmaz, M.A, Bria, E, Carbognin, L, Bonetti, F, Barbareschi, M, Luchini, C

Volltext

CORE-URO-01 study: comparison of safety and efficacy of pazopanib in first-line metastatic renal cell carcinoma (mRCC) with or without renal failure von Masini, C., Vitale, M.G., Maruzzo, M., Procopio, G., De Giorgi, U., Buti, S., Rossetti, S., Iacovelli, R., Guida, A., Atzori, F., Mucciarini, C., Cosmai, L., Vignani, F., Prati, G., Scagliarini, S., Berselli, A., Pinto, C.

Volltext

Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: A multicenter retrospective analysis von De Lisi, D, Maruzzo, M, Galli, L, Biasco, E, Farnesi, A, Procopio, G, Ratta, R, Buti, S, Sternberg, C.N, Cerbone, L, Di Lorenzo, G, Pantano, F, Sterpi, M, De Giorgi, U, Berardi, R, Torinai, M, Camerini, A, Massari, F, Tonini, G, Santini, D

Volltext

2603 Complete remission (CR) during treatment for metastatic renal cell carcinoma (mRCC) with tyrosine kinase inhibitors (TKIs) von Santini, D, Santoni, M, Conti, A, Procopio, G, Verzoni, E, Galli, L, Di Lorenzo, G, De Giorgi, U, De Lisi, D, Nicodemo, M, Maruzzo, M, Massari, F, Buti, S, Biasco, E, Ricotta, R, Porta, C, Vincenzi, B, Marchetti, P, Cascinu, S, Tonini, G

Volltext

Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma von Choueiri, Toni K., Powles, Thomas, Albiges, Laurence, Burotto, Mauricio, Szczylik, Cezary, Zurawski, Bogdan, Yanez Ruiz, Eduardo, Maruzzo, Marco, Suarez Zaizar, Alberto, Fein, Luis E., Schutz, Fabio A., Heng, Daniel Y.C., Wang, Fong, Mataveli, Fabio, Chang, Yu-Lin, van Kooten Losio, Maximiliano, Suarez, Cristina, Motzer, Robert J.

Volltext

1604P Aggregated analysis of treatment and survival outcome of all metastatic renal cell carcinoma patients treated from 2014 to 2018 in the Veneto region, Italy von Basso, U., Tognazzo, S., Bortolami, A., Maruzzo, M., Ballestrin, M., Bimbatti, D., Pierantoni, F., Zagonel, V.

Volltext

1655P Association of location of BRCA1/2 pathogenic variants with benefit from PARP-inhibitors in metastatic castration-resistant prostate cancers: Results from the PROGRESS study von Incorvaia, L., Maruzzo, M., Basso, U., Antonuzzo, L., Rizzo, M., Conteduca, V., Messina, C., Bracarda, S., Mammone, G., Scagliarini, S., Maiorano, B.A., Santoni, M., Facchini, G., Lipari, H., Formisano, L., Malapelle, U., Bazan Russo, T.D., Puglisi, M., Bazan, V., Russo, A.

Volltext

1691P Subcutaneous nivolumab (NIVO SC) vs intravenous nivolumab (NIVO IV) in patients (pts) with previously treated advanced or metastatic clear cell renal cell carcinoma (ccRCC):... von Albiges, L., Bourlon de los Rios, M.T., Chacon, M., Cutuli, H.J., Lopez Chuken, Y.A., Mota, J., Magri, I., Burotto, M., Luz, M.D.A., Menezes, J., Yanez Ruiz, E.P., Maruzzo, M., Bracarda, S., Breckenridge, M., Rathod, D., Yu, Z., Vezina, H., George, S.

Volltext

Glycosaminoglycan Profiling in Patients’ Plasma and Urine Predicts the Occurrence of Metastatic Clear Cell Renal Cell Carcinoma von Gatto, Francesco, Volpi, Nicola, Nilsson, Helén, Nookaew, Intawat, Maruzzo, Marco, Roma, Anna, Johansson, Martin E., Stierner, Ulrika, Lundstam, Sven, Basso, Umberto, Nielsen, Jens

Volltext

1984P Sex differences in anticancer treatment delivery and toxicity in patients with sarcoma in a reference center von Tortorelli, I., Chiusole, B., Murtas, F., Galiano, A., Bolshinsky, M., Djaballah, S. Ahcene, De Toni, C., Vizzaccaro, S., Maruzzo, M., Basso, U., Banzato, A., Coppola, M., Zagonel, V., Brunello, A.

Volltext

1895P Time to treatment failure (TTF) and treatment beyond progression (TBP) in pretreated metastatic renal cell carcinoma (mRCC) patients (pts) receiving nivolumab: A survival out... von Rebuzzi, S.E., Signori, A., Buti, S., Maruzzo, M., De Giorgi, U.F.F., Zucali, P.A., Procopio, G., Fratino, L., Pipitone, S., Mollica, V., Soraru, M., Chiellino, S., Lipari, H., Galli, L., Masini, C., Naglieri, E., Milella, M., Ricotta, R., Banna, G.L., Fornarini, G.

Volltext

1901P Specific dynamic changes of peripheral blood immune profile (PBIP) associate with clinical response to nivolumab (NIVO) in patients (pts) with metastatic renal cell carcinoma... von Verzoni, E., Procopio, G., Bottiglieri, A., Stellato, M., Rametta, A., Zucali, P.A., Perrucci, B., G. fornarini, Buti, S., Maruzzo, M., Cova, A., Squarcina, P., Lalli, L., Mereu, A., Cerioli, N., Agnelli, L., Todoerti, K., Busico, A., Rivoltini, L., Huber, V.

Volltext